GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Establishment Labs Holdings Inc (NAS:ESTA) » Definitions » Piotroski F-Score

Establishment Labs Holdings (Establishment Labs Holdings) Piotroski F-Score : 4 (As of Jun. 05, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Establishment Labs Holdings Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Establishment Labs Holdings has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Establishment Labs Holdings's Piotroski F-Score or its related term are showing as below:

ESTA' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 6
Current: 4

During the past 8 years, the highest Piotroski F-Score of Establishment Labs Holdings was 6. The lowest was 2. And the median was 3.


Establishment Labs Holdings Piotroski F-Score Historical Data

The historical data trend for Establishment Labs Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Establishment Labs Holdings Piotroski F-Score Chart

Establishment Labs Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial 4.00 5.00 4.00 3.00 2.00

Establishment Labs Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 3.00 2.00 2.00 4.00

Competitive Comparison of Establishment Labs Holdings's Piotroski F-Score

For the Medical Devices subindustry, Establishment Labs Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Establishment Labs Holdings's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Establishment Labs Holdings's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was -16.745 + -29.273 + -20.542 + -16.202 = $-82.8 Mil.
Cash Flow from Operations was -28.24 + -31.511 + -8.148 + -11.152 = $-79.1 Mil.
Revenue was 48.561 + 38.506 + 31.56 + 37.167 = $155.8 Mil.
Gross Profit was 30.261 + 26.052 + 20.585 + 24.38 = $101.3 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(209.359 + 285.299 + 270.533 + 268.641 + 301.838) / 5 = $267.134 Mil.
Total Assets at the begining of this year (Mar23) was $209.4 Mil.
Long-Term Debt & Capital Lease Obligation was $195.4 Mil.
Total Current Assets was $203.7 Mil.
Total Current Liabilities was $48.0 Mil.
Net Income was -37.106 + -18.608 + -13.562 + -11.942 = $-81.2 Mil.

Revenue was 41.19 + 38.245 + 43.813 + 46.524 = $169.8 Mil.
Gross Profit was 27.454 + 26.04 + 28.165 + 30.079 = $111.7 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(141.556 + 199.883 + 187.653 + 211.061 + 209.359) / 5 = $189.9024 Mil.
Total Assets at the begining of last year (Mar22) was $141.6 Mil.
Long-Term Debt & Capital Lease Obligation was $182.1 Mil.
Total Current Assets was $142.0 Mil.
Total Current Liabilities was $41.5 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Establishment Labs Holdings's current Net Income (TTM) was -82.8. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Establishment Labs Holdings's current Cash Flow from Operations (TTM) was -79.1. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=-82.762/209.359
=-0.3953114

ROA (Last Year)=Net Income/Total Assets (Mar22)
=-81.218/141.556
=-0.57375173

Establishment Labs Holdings's return on assets of this year was -0.3953114. Establishment Labs Holdings's return on assets of last year was -0.57375173. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Establishment Labs Holdings's current Net Income (TTM) was -82.8. Establishment Labs Holdings's current Cash Flow from Operations (TTM) was -79.1. ==> -79.1 > -82.8 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=195.366/267.134
=0.73134083

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=182.063/189.9024
=0.95871879

Establishment Labs Holdings's gearing of this year was 0.73134083. Establishment Labs Holdings's gearing of last year was 0.95871879. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=203.695/48.016
=4.24223176

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=142.041/41.471
=3.42506812

Establishment Labs Holdings's current ratio of this year was 4.24223176. Establishment Labs Holdings's current ratio of last year was 3.42506812. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Establishment Labs Holdings's number of shares in issue this year was 27.788. Establishment Labs Holdings's number of shares in issue last year was 24.678. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=101.278/155.794
=0.65007638

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=111.738/169.772
=0.65816507

Establishment Labs Holdings's gross margin of this year was 0.65007638. Establishment Labs Holdings's gross margin of last year was 0.65816507. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=155.794/209.359
=0.74414761

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=169.772/141.556
=1.19932747

Establishment Labs Holdings's asset turnover of this year was 0.74414761. Establishment Labs Holdings's asset turnover of last year was 1.19932747. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+1+0+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Establishment Labs Holdings has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Establishment Labs Holdings  (NAS:ESTA) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Establishment Labs Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Establishment Labs Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Establishment Labs Holdings (Establishment Labs Holdings) Business Description

Traded in Other Exchanges
Address
Coyol Free Zone, Building B15 and 25, Alajuela, CRI
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Executives
Nicholas Sheridan Lewin director, 10 percent owner 3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Raj Denhoy officer: Chief Financial Officer C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Dennis E Condon director 811 ALSTON RD, SANTA BARBARA CA 93108
Leslie Gillin director C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Paul D. Rodio officer: Chief Operating Officer C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Samuel Ross Mansbach other: GC & Chief Compliance Officer C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Jw Asset Management, Llc 10 percent owner, other: See Footnote(1) 1051 N VENETIAN DRIVE, MIAMI BEACH FL 33139
Bryan Slotkin director C/O MOTIVA USA,.LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Ann Custin director C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Edward J Schutter director C/O FIRST HORIZON PHARMACEUTICAL CORP, 6195 SHILOH ROAD, ALPHARETTA GA 30005
Lisa Gersh director C/O HASBRO, INC., 1011 NEWPORT AVENUE, PAWTUCKET RI 02861
Mezerville Roberto De officer: Chief Technology Officer C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Renee Gaeta officer: Chief Financial Officer C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Pratip Dastidar officer: Head of Global Operations 150 PEABODY PLACE, MEMPHIS TN 38103
Santos Salvador Dada officer: Chief Operating Officer C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958